Equity Analysis /
United States of America

US : Pharmaceuticals - Specialty Pharmaceuticals | Dec. 2021 ANDA Stats - Poetic End for a 'Year to Forget' as Approvals Hit Lowest Total Since 2018

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    7 January 2022
    Published by